BriaCell Therapeutics (OTCMKTS:BCTXF) Stock Price Down 2.3% – Time to Sell?

Posted by Dante Gardener on Jan 29th, 2025

Shares of BriaCell Therapeutics Corp. (OTCMKTS:BCTXF – Get Free Report) were down 2.3% during mid-day trading on Monday . The company traded as low as $0.39 and last traded at $0.40. Approximately 380,070 shares changed hands during mid-day trading, an increase of 20,345% from the average daily volume of 1,859 shares. The stock had previously closed at $0.41.

BriaCell Therapeutics Trading Down 2.6 %

The company has a market capitalization of $298,532.40, a P/E ratio of 0.00 and a beta of 1.09. The business’s fifty day moving average price is $0.64 and its 200 day moving average price is $0.71.

BriaCell Therapeutics Company Profile

(Get Free Report)

BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT.